Hostname: page-component-7479d7b7d-t6hkb Total loading time: 0 Render date: 2024-07-11T13:37:29.958Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of in vitro fermentation of oats (Avena sativa) and barley (Hordeum vulgare) on the faecal gut microbiota

Published online by Cambridge University Press:  15 April 2015

A. J. Chappell ,
F. Thies ,
P. Martin ,
H.J. Flint  and
K. P. Scott
A. J. Chappell
Affiliation:
Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB25 9SB
F. Thies
Affiliation:
Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB25 9SB
P. Martin
Affiliation:
Agronomy Institute, Orkney College, University of the Highlands and Islands, Orkney, KW15 1LX
H.J. Flint
Affiliation:
Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB25 9SB
K. P. Scott
Affiliation:
Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, AB25 9SB
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
Type
Abstract
Information
Proceedings of the Nutrition Society , Volume 74 , Issue OCE1: Summer Meeting, 14–17 July 2014, Carbohydrates in health: friends or foes , 2015 , E32
Copyright
Copyright © The Authors 2015 

Diets high in whole grain cereals may reduce the risk of cardiovascular disease (CVD) and colorectal cancerReference Hotchkiss, Davies and Gray1−Reference Eshak, Iso and Date2. Mixed link β-glucans found within oats (Avena sativa) and barley (Hordeum vulgare) could be partly responsible for this. The cholesterol lowering effect of oat β-glucans currently has several endorsed health claims including the U.S Food and Drug Administration (FDA) and the European Food Safety Authority3–4. β-glucans may also reduce the risk of disease by increasing satiety, reducing body mass index, lowering blood glucose and increasing stool transit time. Little is known about how β-glucans influence the gut microbiota. However, the development of culture independent techniques using 16S rRNA-targeting arrays have demonstrated the importance of bacterial community composition, and bacterial metabolites, in health and disease. Prebiotics are defined as non-digestible plant derived carbohydrates that act as fermentation substrates that stimulate the preferential growth and activity of microbial species that confer health benefits to the host. Understanding how prebiotics the influence gut microbiota is a growing area of interestReference Kellow, Coughlan and Reid5.

Here we investigated the effects of different cultivars of oats and barley on microbial activity and composition. Firstly a batch culture experiment was performed using faecal inocula from four different volunteers. Five cultivars were compared; pH and short chain fatty acid (SCFA) concentrations were measured at 0, 24, and 48 h. After 48 h, pH significantly decreased by at least 1·1 unit in all incubations, while SCFA concentrations significantly increased (p < 0·05). No difference was observed between incubations. This was followed by a continuous flow fermentor, where two cultivars were compared. The fermentor produced a different SCFA profile compared with the batch experiment. Maintenance of the pH at 5·8 and the continuous flow could have contributed to this.

Microbial analysis of the fermentor samples by fluorescence in situ hybridisation (FISH) found a shift towards Bacteroides genus and a reduction in Firmicutes and Actinobacteria. The bacterial composition and SCFA ratios were very similar between the oats and barley cultivars. However, significantly more butyrate was produced compared to the high carbohydrate control. As butyrate may have anti-carcinogenic properties, increasing consumption of oats and barley could potentially provide important health benefits.

Fermentor Short Chain Fatty Acids at Day 15

Control was a high mixed carbohydrate medium

Different letters within columns denote significant difference (p < 0·05)

References

1.Hotchkiss, JW, Davies, C, Gray, L, et al. (2011) BMJ 1(1), 1–14.Google Scholar
2.Eshak, ES, Iso, H, Date, C, et al. (2010) J Nutr 140, 1445–1453.Google Scholar
3.EFSA Panel on Dietetic Products, Nutrition and Allergies. (2011) EFSA J 9, 2207.Google Scholar
4.U.S FDA. (1997) Fed Regist 62, 3584–3681.Google Scholar
5.Kellow, NJ, Coughlan, MT, Reid, CM, (2014) BJN 111, 1147–1161.Google Scholar